Ga68-Dolacga Injection
PTK16081821
Phase 1 small_molecule completed
Quick answer
Ga68-Dolacga Injection for Safety Issues is a Phase 1 program (small_molecule) at Taiwan Liposome Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiwan Liposome Company
- Indication
- Safety Issues
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed